TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO

Targeted Stem Cells Expressing TRAIL as a Therapy for Lung Cancer

NCT03298763 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC)

NCT00419042 ·Status: COMPLETED

A Study of TRC105 in Combination With Paclitaxel/Carboplatin and Bevacizumab in Non-Squamous Cell Lung Cancer

NCT02429843 ·Status: COMPLETED ·Phase: PHASE1

Cisplatin, Etoposide, and Bevacizumab in Treating Patients With Previously Untreated Extensive Stage Small Cell Lung Cancer

NCT00079040 ·Status: COMPLETED ·Phase: PHASE2

A Study of Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer Naive to Chemotherapy

NCT02013206 ·Status: COMPLETED ·Phase: PHASE2

Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC

NCT03786692 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Locally Advanced NSCLC Treated With Radiochemotherapy: Phase 2 Study on the Value of a Stereotactic Boost

NCT06627738 ·Status: RECRUITING ·Phase: PHASE2

TORCH: A Study of Tarceva or Chemotherapy for the Treatment of Advanced Non Small Cell Lung Cancer

NCT00349219 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

NCT00091663 ·Status: COMPLETED ·Phase: PHASE3

Combination of Paclitaxel-bevacizumab ± Atezolizumab in Patients With Advanced NSCLC Progressing After Immunotherapy & Chemotherapy

NCT05781308 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)

NCT00556712 ·Status: COMPLETED ·Phase: PHASE3

Trastuzumab Plus Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer

NCT00003881 ·Status: COMPLETED ·Phase: PHASE2

A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer

NCT02735980 ·Status: COMPLETED ·Phase: PHASE2

Combination of Erlotinib and Bevacizumab as Second-line Treatment in Patients With Non-small Cell Lung Cancer

NCT00749567 ·Status: TERMINATED ·Phase: PHASE2

Patient-derived Tumor-like Cell Cluster Model-based Precision Treatment Strategy on Non-small Cell Lung Cancer

NCT07328945 ·Status: RECRUITING

Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer

NCT00408499 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Therapeutic Strategy in Advanced Bronchioloalveolar Carcinoma

NCT00384826 ·Status: COMPLETED ·Phase: PHASE2

Optimization for the Treatment of Advanced Pulmonary Large Cell Neuroendocrine Carcinoma

NCT02943798 ·Status: UNKNOWN ·Phase: PHASE2

Genetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

NCT02132884 ·Status: TERMINATED ·Phase: NA

Study of Tarceva and Targretin in Stage I-II Lung Cancer

NCT00125372 ·Status: COMPLETED ·Phase: NA

Precision Cell Immunotherapy Combined With Chemotherapy in Advanced Lung Cancer

NCT02873416 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Tiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced Non-squamous NSCLC

NCT04958811 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Nivolumab in Combination With Chemotherapy, or Nivolumab in Combination With Ipilimumab, in Advanced EGFR-Mutant or ALK-Rearranged NSCLC

NCT03256136 ·Status: COMPLETED ·Phase: PHASE2

A Study of Tarceva (Erlotinib) in Combination With Platinum Based Chemotherapy in Patients With Non-Small Cell Lung Cancer.

NCT01998919 ·Status: COMPLETED ·Phase: PHASE2

Patient and Physician Preference Study in Resectable, Non-small Cell Lung Cancer Treatments

NCT06448793 ·Status: RECRUITING